PMS2 and ovarian cancer: As shown in Table 3, while high levels of MLH1 were associated with a better OS in grade III ovarian cancers and increased mRNA expression of PMS2 was positively correlated with OS in grade II ovarian cancer, MSH6 mRNA expression was a favorable predictor of OS both in grade II and grade III ovarian cancer patients.